Introduction
Thymidine synthesis is impaired in cells from patients with untreated megaloblastic anaemia. At a biochemical level there is depressed conversion of deoxyuridine (dU) to deoxythymidine. Both folate and cobalamin are required for this step which involves the transfer of a single-carbon unit (-CH2 or methylene) from methylenetetrahydrofolate to dU. During this transfer, by thymidylate synthetase, the methylene group is reduced to methyl . The dU suppression test performed on marrow samples tests this step by noting first, how the cells use dU to make thymidine and, subsequently, if their thymidine requirements have not been met from dU, how much preformed labelled thymidine they are able to use (Killman, 1964; Metz et al., 1968) . If the marrow cells are able to convert dU into thymidine effectively very little of the exogenous thymidine will be used. Cells that do not use dU normally will take up larger amounts of added labelled thymidine. Experience indicates that the test is abnormal in almost all patients with megaloblastic anaemia (Chanarin, 1979) . The defect is corrected on the addition of cobalamin to marrow from cobalamin-deficient patients and the result is improved in all megaloblastic marrows on the addition of most folate compounds.
Studies using marrow from rats, both controls and animals in which cobalamin had been inactivated by nitrous oxide, made it possible to test a much wider range of folate analogues (Deacon et al., 1980) . The results indicated that in the rat, addition of formylfolates were much more effective in overcoming the block produced by B12 inactivation than other folates and that the result could be significantly affected by the addition of folate to the control tube (lacking dU). Bain (1975) and Rogers and Lietman (1977) showed that the addition of folate to the culture medium reduced uptake of 3H-thymidine by stimulated lymphocytes.
Wickramasinghe and Saunders (1979) reported lower dU values in 2 out of 8 tests when additions of vitamins were made to the control tube. Apart from this paper this aspect has not received a great deal of attention in interpreting data from the dU suppression tests.
The purpose of this study was to explore the effect on thymidine requirements of adding folate analogues to marrow from megaloblastic patients and control subjects and, secondly, to assess the effect of such modified controls on the results of the dU suppression test. Similar studies were made with rat marrow both from control and N20-treated animals.
Materials and methods Patients studied
Marrow samples were obtained from 11 patients with untreated megaloblastic anaemia, 6 due to pernicious anaemia and 5 to folate deficiency. In addition, observations were made on 4 marrows from haematologically normal patients. These had been requested as part of the investigation of the patient.
Animals
Male, Sprague-Dawley, 80-to 120-g rats were placed in a chamber in which a mixture of N20 (50%) and oxygen (50%) was passed, and CO2 and humidity controlled. After 3 hr the animals were killed by exsanguination preceded by an injection of sodium pentobarbitone, long bones removed, split with a scalpel and marrow washed into 5 ml cold Hanks's balanced salt solution (BSS) (pH 7-2-7-4) containing 0 5 ml preservative-free heparin (1000 i.u./ml). Control animals were left in air.
Marrow
The marrow collected in Hanks's solution was passed through 21- [3H]thymidine uptake alone
The tests consisted of duplicate tubes, one set containing marrow cells and thymidine and the other set the additive (see below), marrow cells and thymidine. Volumes of reagents, incubation and processing was as for the dU suppression test.
Solutions
The following were added in the dU suppression test and in the thymidine uptake study: hydroxocobalamin (OHCbl) 1 mg/ml, DL 5-CHO-H4PteGlu (Lederle) 3 mg/ml, PteGlu 1-5 mg/ml, DL 5-CH3-H4PteGlu (Sigma) 3 mg/ml in 0-1 M potassium phosphate buffer pH 7'0 to which was added 10 mM 2-mercaptoethanol, DL H4PteGlu (Sigma) 3 mg/ml in 1 % potassium ascorbate pH 6 5 stored under nitrogen, 10-CHO-H4PteGlu 3 mg/ml prepared from 5-CHO-H4PteGlu (Sigma) by the method of Rabinowitz (1963) stability of folate analogues used in these studies. One per cent. ascorbate pH 6 5 had no effect in the dU suppression test using rat marrow, nor was there any effect produced by the buffer solution in which 10-CHO-H4PteGlu was dissolved. However, the 0-1 M potassium phosphate buffer with 2-mercaptoethanol used to preserve 5-CH3-H4PteGlu had a significant effect on the result of the dU suppression test which fell from 10 9 and 1050% to 8-4 and 6.9o%
in 2 tests respectively.
The effect of cobalamin and/or folate analogues on
[3H]thymidine uptake by marrow cells In these studies, B12 and/or folate were first added to marrow suspensions followed by [3H]thymidine. B12 or folate were omitted from a second set of tubes to which thymidine alone was added. These served as controls. In each study the uptake of
[3H]thymidine in the control (100%) was compared with that in the presence of the additive.
There were significant reductions of thymidine uptake after the additions of tetrahydrofolate and its 10-formyl derivative to rat marrow (P>0-001) ( Table 2) . Results of individual experiments in control rats are shown in Fig. 1 . Generally similar results were obtained on control and N20-treated rats (with the exception of 10-CHO-H4PteGlu) and the effects were more severe when both B12 and folate analogues were added together.
By contrast the addition of methylfolate enhanced the uptake of thymidine.
Data using normal human marrow cells (Table 3 The effect of cobalamin/Jolate on the result of the deoxyuridine suppression test Results of the dU suppression test using marrow from rats breathing air and breathing N20/oxygen (1/1) are shown in Table 4 and Fig. 3 . As reported elsewhere (Deacon et al., 1980) , exposure to N20 impairs the synthesis of thymidine and hence the (Fig. 4) marrows and in marrows from rats in whom cobalamin had been inactivated by inhaling a mixture of oxygen and nitrous oxide (1/1). In the tests shown as a filled circle, folate or cobalamin was not added to the control tubes which had marrow and thymidine only. In the tests shown by the unfilled circle, folate and/or cobalamin were added to control tubes as well as to tubes containing first dU and then 3H-thymidine.
Discussion
The effect of folates and cobalamins on the uptake of labelled thymidine may be complex and an attempt to account for these findings in terms of the known pathways involving these cofactors may be an oversimplification (Pelliniemi and Beck, 1980 Stokstad, 1967) . Another hypothetical explanation for the effect of methylfolate is that it blocks folate receptors on the cell surface and prevents transport of folate across cell membranes. Cobalamin deficiency and cobalamin inactivation by N20, both interfere with tissue uptake of folates. The mechanism of this is unexplored as yet but gross abnormalities in red cell membranes in megaloblastic patients have been described (Ballas, 1978 (1979) have suggested that the omission of the additive in the control tube in the dU suppression test is a defect in its design. While in agreement with this viewpoint it should also be stated that such an addition did not make a significant difference to the results with human material. The results with this test in megaloblastic anaemia are so satisfactory that it would have been surprising to find a major anomaly in its design. Nevertheless there may be marginal differences in some individual cases. The advantage of fully matched controls is evident in the results with rat marrows. With marrows from healthy rats the use of matched controls brought all the mean values with normal marrows to within a very narrow range and this is the justification for using this base in interpreting data in N20-treated animals. Unlike the test with human marrow, comparing matched and unmatched control resulted in significant differences in the result when tetrahydrofolate, 10-formyltetrahydrofolate and 5-methyltetrahydrofolate were added in the performance of the dU suppression test. 
